Arm rose 2.6% Saudi sovereign wealth fund PIF opened a new position in the first quarter and bought Arm call options

Related posts

• Holding companies outpace Nifty, Sensex in returns: Way2Wealth report

  Holding companies index outperformed the benchmark index over a longer investment horizon, according to a report by brokerage firm Way2Wealth. Returns of the eight holding companies covered by the study were at 95 per cent, 26 per cent and 27 per cent over a one-year return, five-year CAGR, and 10-year CAGR, respectively. This outpaced the returns of Nifty 50 index and Sensex at 27/23 per cent, 14 per cent and 13 per cent during the respective period.

  US stock market April 24, 2024

• Sebi bars Growpital, other related entities from securities markets; probe continues

  Markets regulator Sebi said that Farm Tech Silo LLP, also known as Growpital, other related entities and their directors will remain barred from securities markets till the outcome of a probe into collection of money through unauthorised investment schemes.

  US stock market April 29, 2024

• Polestar failed to submit its annual report on time, Nasdaq issued a violation notice

  Polestar announced on May 17 that due to the failure to submit its annual report as of December 31, 2023, the company received a notice from Nasdaq confirming that the company did not comply with the provisions of the Nasdaq listing rules. requires the timely filing of all required periodic financial reports with the Securities and Exchange Commission

  US stock market May 19, 2024

• Nordisk fell 1.1% in premarket as the U.S. Senate launches investigation into Novo Nordisk\’s GLP-1 drug pricing

  Gelonghui, April 25 | Nord Nordisk (NVO.US) U.S. stocks fell 1.1% before the market opened, to US$124.74. On the news, U.S. Senate Health, Education, Labor and Pensions Committee Chairman Bernie Sanders said on Wednesday that the committee is launching an investigation into Novo Nordisk\’s pricing. In a letter sent to Novo Nordisk\’s CEO on Wednesday, Sanders asked Novo Nordisk to provide \”internal communications about the U.S. pricing of the drug\” and explain why Ozempic and Wegovy have the same ingredient (semaglutide). ), Wegovy’s pricing is obviously more expensive. Sanders stressed that the price of GLP-1 drugs \”must come down\” so that consumers can afford them and the government doesn\’t go bankrupt by reimbursing them.

  US stock market April 25, 2024

• Musk says he\’s working on Chapter 4 of Tesla\’s grand plan

  Musk said on Monday that he has begun work on the next phase of Tesla\’s Master Plan series, known as Part 4, the third part of which was announced last year.

  US stock market June 18, 2024

• Hedge fund Rokos executive: Fed unlikely to cut interest rates this year

  Richard Tang, global head of markets at hedge fund Rokos Capital Management, believes the Fed is unlikely to loosen monetary policy this year.

  US stock market May 16, 2024